A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers
Clinical trial NCT04238364 · COMPLETED
Trial details
- NCT number
- NCT04238364
- Sponsor
- Elixiron Immunotherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-27
- Primary completion
- 2021-12-16
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.